206 related articles for article (PubMed ID: 30298827)
21. Combretastatin linked 1,3,4-oxadiazole conjugates as a Potent Tubulin Polymerization inhibitors.
Kamal A; Srikanth PS; Vishnuvardhan MV; Kumar GB; Suresh Babu K; Hussaini SM; Kapure JS; Alarifi A
Bioorg Chem; 2016 Apr; 65():126-36. PubMed ID: 26943479
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents.
El Mansouri AE; Oubella A; Mehdi A; AitItto MY; Zahouily M; Morjani H; Lazrek HB
Bioorg Chem; 2021 Mar; 108():104558. PubMed ID: 33358270
[TBL] [Abstract][Full Text] [Related]
24. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T
Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555
[TBL] [Abstract][Full Text] [Related]
25. Design, Synthesis, and Antitumor Activity of Novel 5-Pyridyl-1,3,4-oxadiazole Derivatives against the Breast Cancer Cell Line MCF-7.
Khalil NA; Kamal AM; Emam SH
Biol Pharm Bull; 2015; 38(5):763-73. PubMed ID: 25947922
[TBL] [Abstract][Full Text] [Related]
26. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells.
Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory growth evaluation and apoptosis induction in MCF-7 cancer cells by new 5-aryl-2-butylthio-1,3,4-oxadiazole derivatives.
Khanam R; Ahmad K; Hejazi II; Siddique IA; Kumar V; Bhat AR; Azam A; Athar F
Cancer Chemother Pharmacol; 2017 Nov; 80(5):1027-1042. PubMed ID: 28815320
[TBL] [Abstract][Full Text] [Related]
28. Pyrazole-oxadiazole conjugates: synthesis, antiproliferative activity and inhibition of tubulin polymerization.
Kamal A; Shaik AB; Polepalli S; Reddy VS; Kumar GB; Gupta S; Krishna KV; Nagabhushana A; Mishra RK; Jain N
Org Biomol Chem; 2014 Oct; 12(40):7993-8007. PubMed ID: 25181296
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents.
El Mansouri AE; Oubella A; Maatallah M; AitItto MY; Zahouily M; Morjani H; Lazrek HB
Bioorg Med Chem Lett; 2020 Oct; 30(19):127438. PubMed ID: 32736079
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the apoptotic pathway induced by benzimidazole-oxindole conjugates against human breast cancer cells MCF-7.
Lakshma Nayak V; Nagaseshadri B; Vishnuvardhan MVPS; Kamal A
Bioorg Med Chem Lett; 2016 Jul; 26(14):3313-3317. PubMed ID: 27262596
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
Li H; Wang K; Wan Q; Chen Y
Steroids; 2019 Jan; 141():81-95. PubMed ID: 30521816
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, cytotoxicity, and molecular docking of substituted 3-(2-methylbenzofuran-3-yl)-5-(phenoxymethyl)-1,2,4-oxadiazoles.
Mokenapelli S; Thalari G; Vadiyaala N; Yerrabelli JR; Irlapati VK; Gorityala N; Sagurthi SR; Chitneni PR
Arch Pharm (Weinheim); 2020 Jun; 353(6):e2000006. PubMed ID: 32309890
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro antiproliferative activity of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
Eur J Med Chem; 2015 Jan; 90():45-52. PubMed ID: 25461310
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel heteroarylmethylcarbamodithioates as potent anticancer agents: Synthesis, structure-activity relationship analysis and biological evaluation.
Li YB; Yan X; Li RD; Liu P; Sun SQ; Wang X; Cui JR; Zhou DM; Ge ZM; Li RT
Eur J Med Chem; 2016 Apr; 112():217-230. PubMed ID: 26900655
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of 3,4-diaryl-1,2,5-oxadiazole-2/5-oxides as highly potent inhibitors of tubulin polymerization.
Hong Y; Zhao Y; Yang L; Gao M; Li L; Man S; Wang Z; Guan Q; Bao K; Zuo D; Wu Y; Zhang W
Eur J Med Chem; 2019 Sep; 178():287-296. PubMed ID: 31195170
[TBL] [Abstract][Full Text] [Related]
36. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
37. 1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells.
Valente S; Trisciuoglio D; De Luca T; Nebbioso A; Labella D; Lenoci A; Bigogno C; Dondio G; Miceli M; Brosch G; Del Bufalo D; Altucci L; Mai A
J Med Chem; 2014 Jul; 57(14):6259-65. PubMed ID: 24972008
[TBL] [Abstract][Full Text] [Related]
38. Bisindole-oxadiazole hybrids, T3P
Kamath PR; Joseph MM; Abdul Salam AA; Therakathinal ST; Sunil D; Biswas S; Pai KSR
J Biochem Mol Toxicol; 2017 Nov; 31(11):. PubMed ID: 28724188
[TBL] [Abstract][Full Text] [Related]
39. New promising levofloxacin derivatives: Design, synthesis, cytotoxic activity screening, Topo2β polymerase inhibition assay, cell cycle apoptosis profile analysis.
El-Malah A; Youssef A; Ismail M; Kamel M; Mahmoud Z
Bioorg Chem; 2021 Aug; 113():105029. PubMed ID: 34091290
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity.
ElZahabi HSA; Nafie MS; Osman D; Elghazawy NH; Soliman DH; El-Helby AAH; Arafa RK
Eur J Med Chem; 2021 Oct; 222():113609. PubMed ID: 34119830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]